GenEdit: Roche's Genentech and GenEdit enter autoimmune disease partnership worth up to $644m
The companies will develop nanoparticles to deliver genetic medicines for autoimmune diseases
Read full article »
GenEdit is a California-based biotechnology company that develops and commercializes curative therapies for the treatment of genetic diseases.
Read more